Year archive

Immuron Ltd — 2011 filings

All 49 regulatory filings released by Immuron Ltd (IMRN) in 2011, sourced directly from the official regulator.

49 Filings

2011 Period

2011 filings (49)

Filing	Released	Lang
Appendix 3B Issue of Options - Executive Share Option Plan 7 pages 54.7KB Capital/Financing Update	2011-12-19	English
Research agreement with Harvard Medical School 1 pa Regulatory Filings	2011-12-15	English
AGM Chairman`s address, presentations and results of meeting 78 pages 3.4MB AGM Information	2011-11-29	English
Appendix 3B 7 pages 54.8KB Capital/Financing Update	2011-11-29	English
Travelan Licence Deal with Paladin Labs Inc. Canada 2 pages 93.0KB Capital/Financing Update	2011-11-28	English
Appendix 3B and top 20 share and option holder reports 14 pages 124.2KB Capital/Financing Update	2011-11-07	English
Change of Director`s Interest Notice 5 pages 87.5KB Director's Dealing	2011-11-07	English
Immuron submits NASH IND Application with FDA 2 pages 77.1KB Regulatory Filings	2011-11-06	English
Non-Renounceable Issue Shortfall 1 page 57.4KB Capital/Financing Update	2011-11-03	English
Notice of Annual General Meeting/Proxy Form 23 pages 524.9KB AGM Information	2011-10-23	English
Extension of Closing Date for Non-Renounceable Share Offer 1 Capital/Financing Update	2011-09-28	English
Annual Report for Year Ended 30 June 2011 56 pages 520.3KB Annual Report FY 2011	2011-09-28	English
Extension of Closing Date for Non-Renounceable share Offer 1 Capital/Financing Update	2011-09-18	English
Revised Closing Date Non-Renounceable Rights Offer 1 Capital/Financing Update	2011-09-18	English
Research Report on NASH and Influenza Drug Candidates 1 Report Publication Announcement	2011-09-05	English
Chief Executive Officer`s presentation to General Meeting 31 pages 1.4MB Investor Presentation	2011-09-04	English
Results of General Meeting held on 5 September 2011 1 Declaration of Voting Results & Voting Rights Announcements	2011-09-04	English
Results for Announcement to the Market 2 pages 15.9KB Annual Report FY 2011	2011-08-30	English
Preliminary Final Report 12 pages 58.2KB Annual Report FY 2011	2011-08-30	English
Offer Document for Non-Renounceable Rights Issue 21 pages 452.8KB Capital/Financing Update	2011-08-30	English
Immuron`s Novel Influenza Product Advances to Human Trial 1 Regulatory Filings	2011-08-28	English
Becoming a substantial holder Notice 3 pages 1.2MB Regulatory Filings	2011-08-28	English
Appendix 3B Issue of shares and options 7 pages 54.5KB Share Issue/Capital Change	2011-08-24	English
Letter to Shareholders re Non-Renounceable Rights Issue 4 pages 418.2KB Regulatory Filings	2011-08-23	English
Letter to Option Holders re Non-Renounceable Rights Issue 1 Capital/Financing Update	2011-08-23	English
Letter to Overseas S/holders re Non-Renounceble Rights Issue 1 Capital/Financing Update	2011-08-23	English
Phase 2B NASH trial on track following meeting with FDA 2 pages 61.2KB Regulatory Filings	2011-08-21	English
Notice of Non-Renounceable Rights Issue 2 pages 30.1KB Capital/Financing Update	2011-08-16	English
Appendix 3B- Non Renounceable Rights Issue 7 pages 55.4KB Capital/Financing Update	2011-08-16	English
Amended Appendix 3B 7 pages 55.5KB Capital/Financing Update	2011-08-16	English
Cleansing Notice 3 pages 46.5KB Capital/Financing Update	2011-08-16	English
Notice of General Meeting 5 September 2011 11 pages 508.2KB AGM Information	2011-08-02	English
Travelan discovered to affect E.coli O104 outbreak in Europe 1 Regulatory Filings	2011-07-25	English
HIV Program proceeds to Expanded Human Trial 1 page Regulatory Filings	2011-07-20	English
Attendance at Bio International Convention - Washington 22 pages 807.6KB Investor Presentation	2011-06-26	English
Issue of Shares and Options - Appendix 3B 7 pages 54.6KB Share Issue/Capital Change	2011-06-26	English
Shareholder Update 6 pages 323.5KB Management Reports	2011-05-31	English
Appointment of Principal Investigator for NASH trial 2 pages 175.4KB Board/Management Information	2011-05-23	English
Section 708A Notice 1 page 29.7KB Capital/Financing Update	2011-05-15	English
Change of Director`s Interest Notice Professor Colin Chapman 2 pages 13.6KB Director's Dealing	2011-05-15	English
Appendix 3B Issue of Shares and Options 7 pages 54.6KB Share Issue/Capital Change	2011-05-11	English
Immuron Granted FDA pre-IND Meeting re Phase 2b Trial 1 Regulatory Filings	2011-04-18	English
Immurons Influenza Program Shows Effectiveness in Trials 2 pages 191.7KB Capital/Financing Update	2011-03-16	English
Important Progress in HIV Prevention Project 4 pages 6.6MB Regulatory Filings	2011-03-07	English
Half Yearly Report and Accounts 17 pages 941.6KB Regulatory Filings	2011-02-28	English
Immuron Granted Key Patent for Influenza Product 1 Capital/Financing Update	2011-02-28	English
Australian Sales of Travelan expected to Increase 1 Regulatory Filings	2011-02-23	English
Appendix 3B 7 pages 54.7KB Share Issue/Capital Change	2011-02-17	English
Appointment of New Chief Executive Officer 2 pages 158.8KB Board/Management Information	2011-01-16	English

Filings by year

2026 25 filings
2025 142 filings
2024 106 filings
2023 79 filings
2022 70 filings
2021 57 filings
2020 118 filings
2019 134 filings
2018 92 filings
2017 142 filings
2016 59 filings
2015 47 filings
2014 44 filings
2013 57 filings
2012 76 filings
2011 49 filings
2010 47 filings
2009 61 filings
2008 46 filings
2007 45 filings
2006 27 filings
2005 28 filings
2004 30 filings
2003 19 filings
2002 4 filings